Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
International Journal of Cell Cloning|May 1, 1986
Parameters affecting the in vitro maturation of human monocytes to macrophagesH Maoz, A Polliack, V Barak, et al.European Journal of Immunology|November 1, 1986
Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20)V Barak, A J Treves, P Yanai, et al.Israel Journal of Medical Sciences|September 1, 1988
Chemotherapy induction, consolidation radiotherapy and maintenance alternating chemotherapy in small cell carcinoma of the lungE Warner-Efrati, A Sulkes, Z Weshler, et al.Oncology|January 1, 1985
A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markersA T Horowitz, A J Treves, R Voss, et al.Journal of Chemotherapy (Florence, Italy)|December 1, 1989
Methylprednisolone versus metoclopramide as antiemetic treatment in patients receiving adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) chemotherapy: a randomized crossover blind studyE Gez, A Sulkes, L Ochayon, et al.Israel Journal of Medical Sciences|September 1, 1988
Involvement of heparanase in tumor metastasis and angiogenesisI Vlodavsky, R I Michaeli, M Bar-Ner, et al.International Surgery|July 1, 1989
Hepatic intraarterial antibiotic therapy for resistant hepatic abscessesT Y Peretz, R Ben-Yosef, P Lebensart, et al.Methods in Molecular Biology (Clifton, N.J.)|April 8, 2025
Identification and Genetic Analysis of Rust Resistance Genes in Wheat for Marker-Assisted SelectionJujhar Singh Gill, Harbans Bariana, Bipan S Biran, et al.American Journal of Clinical Oncology|July 28, 2001
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter studyI G Ron, N Wigler, R Borovik, et al.European Journal of Cancer & Clinical Oncology|December 1, 1989
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I studyA Gabizon, T Peretz, A Sulkes, et al.Pageof 9